|
Transform operational efficiency
and improve patient outcomes
with our high performance
respiratory portfolio
What tools do your teams need for the upcoming respiratory season?
Reliable diagnostic results on a fully connected platform, at the point of care. Helping you improve patient management with reliable and accurate results, all with minimal staff training requirements.
A key customer, Centre Hospitalier Universitaire (CHU) Montpellier, has published data showing the LumiraDx Platform and respiratory tests have enabled them to utilize high-performance results to achieve operational benefits and improved patient outcomes.
Performance
CHU Montpellier analysed the performance of the LumiraDx SARS-CoV-2 Ag Ultra test against laboratory based RT-PCR giving the following results:
The team found that this excellent analytical sensitivity and specificity, plus the speed of results for the 5 minute test, has improved the fluidity of patient care in the emergency department, when compared with the standard pathway using laboratory based RT-PCR.
Transforming operational efficiency
With fast, lab-accurate results, full connectivity, quality control, and ease of use, the LumiraDx Platform can bring significant operational and efficiency improvements.
With a respiratory portfolio covering Covid, Flu A & B and RSV, more patients can be managed through testing in decentralised settings.
CHU Montpellier found a 64% reduction in RT-PCR respiratory testing and 46% rise in antigenic testing between 2022 and 2023 allowing a reorganization of virology laboratory human resources.
GO TO POSTER →
Empowering patients and clinicians
The LumiraDx Platform provides the cornerstone for high-performance across multiple assays, providing clinical assistance to physicians during the difficult winter period. Clinicians and patients get faster results where they need them to triage those with respiratory symptoms quickly.
Hear how the LumiraDx Platform has made a difference to the team at CHU Montpellier, and the benefits it brings to their patients.
WATCH VIDEO →
|